data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Check-Cap
(NASDAQ:CHEK)
$0.3116
0.0026[0.84%]
At close: Jul 1
$0.3011
-0.0105[-3.37%]
After Hours: 4:58PM EDT
Day High/Low0.3 - 0.32
52 Week High/Low0.29 - 1.33
Open / Close0.31 / 0.31
Float / Outstanding116.3M / 116.4M
Vol / Avg.174.8K / 473.4K
Mkt Cap36.3M
P/E-
50d Avg. Price0.35
Div / Yield-
Payout Ratio-
EPS-0.06
Total Float116.3M

Check-Cap (NASDAQ:CHEK), Quotes and News Summary

Check-Cap (NASDAQ: CHEK)

Day High/Low0.3 - 0.32
52 Week High/Low0.29 - 1.33
Open / Close0.31 / 0.31
Float / Outstanding116.3M / 116.4M
Vol / Avg.174.8K / 473.4K
Mkt Cap36.3M
P/E-
50d Avg. Price0.35
Div / Yield-
Payout Ratio-
EPS-0.06
Total Float116.3M
Benzinga - Jun 1, 2022, 8:16AM
Benzinga - May 11, 2022, 8:02AM
Benzinga - Apr 7, 2022, 8:36AM
Benzinga - Mar 1, 2022, 9:27AM
Benzinga - Mar 1, 2022, 8:32AM
Benzinga - Feb 7, 2022, 10:28AM
Benzinga - Feb 7, 2022, 10:19AM
Benzinga - Feb 7, 2022, 8:36AM
Benzinga - Feb 7, 2022, 8:31AM
Benzinga - Jan 5, 2022, 9:18AM
Benzinga - Dec 23, 2021, 4:16PM
Benzinga - Nov 22, 2021, 8:03AM
Benzinga - Nov 3, 2021, 8:32AM
Benzinga - Nov 2, 2021, 3:33PM
Benzinga - Nov 2, 2021, 1:06PM
Benzinga - Nov 2, 2021, 8:35AM
Benzinga - Oct 19, 2021, 9:53AM
Benzinga - Aug 30, 2021, 9:03AM
Benzinga - Aug 10, 2021, 3:15PM
Benzinga - Aug 9, 2021, 6:36AM
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.060-0.060 0.0000
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Check-Cap Questions & Answers

Q
How do I buy Check-Cap (CHEK) stock?
A

You can purchase shares of Check-Cap (NASDAQ: CHEK) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Check-Cap's (CHEK) competitors?
A

There are no as such competitors for Check-Cap.

Q
What is the target price for Check-Cap (CHEK) stock?
A

The latest price target for Check-Cap (NASDAQ: CHEK) was reported by HC Wainwright & Co. on Monday, August 9, 2021. The analyst firm set a price target for 3.00 expecting CHEK to rise to within 12 months (a possible 862.77% upside). 1 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Check-Cap (CHEK)?
A

The stock price for Check-Cap (NASDAQ: CHEK) is $0.3116 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Check-Cap (CHEK) pay a dividend?
A

There are no upcoming dividends for Check-Cap.

Q
When is Check-Cap (NASDAQ:CHEK) reporting earnings?
A

Check-Cap’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Check-Cap (CHEK) going to split?
A

There is no upcoming split for Check-Cap.

Q
What sector and industry does Check-Cap (CHEK) operate in?
A

Check-Cap is in the Healthcare sector and Diagnostics & Research industry. They are listed on the NASDAQ.